Article Information
History
- January 22, 2022.
Article Versions
- Version 1 (September 8, 2021 - 07:13).
- Version 2 (October 8, 2021 - 22:49).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Beth Fitt1,¶,
- Grace Loy1,¶,
- Edward Christopher2,
- Paul M. Brennan3,4,5 and
- Michael T.C. Poon3,4,5,6,*,#a
- 1Edinburgh Medical School, University of Edinburgh, Edinburgh, UK
- 2Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK
- 3Brain Tumour Centre of Excellence, Cancer Research UK Edinburgh Centre, Edinburgh, UK
- 4Translational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- 5Department of Clinical Neuroscience, Royal Infirmary of Edinburgh, Edinburgh, UK
- 6Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK
- ↵*Corresponding author E-mail: michael.poon{at}ed.ac.uk
↵¶ These authors contributed equally to this work
Posted January 22, 2022.
Analytic approaches to clinical validation of results from preclinical models of glioblastoma: a systematic review
